The Great Debate at "Melanoma Bridge", Naples, December 7th, 2019.

Details

Serval ID
serval:BIB_B856D78550C3
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
The Great Debate at "Melanoma Bridge", Naples, December 7th, 2019.
Journal
Journal of translational medicine
Author(s)
Ascierto P.A., Agarwala S.S., Eggermont A., Gershenwald J.E., Grob J.J., Hamid O., Michielin O., Postow M., Puzanov I., Zarour H.M., Caracò C., Testori A.
ISSN
1479-5876 (Electronic)
ISSN-L
1479-5876
Publication state
Published
Issued date
16/04/2020
Peer-reviewed
Oui
Volume
18
Number
1
Pages
171
Language
english
Notes
Publication types: Journal Article
Publication Status: epublish
Abstract
The Great Debate session at the 2019 Melanoma Bridge congress (December 5-7, Naples, Italy) featured counterpoint views from experts on five topical issues in melanoma. These were whether to choose local intratumoral treatment or systemic treatment, whether patients with stage IIIA melanoma require adjuvant therapy or not, whether treatment is better changed at disease progression or during stable disease, whether adoptive cell transfer (ACT) therapy is more appropriate used before or in combination with checkpoint inhibition therapy, and whether treatment can be stopped while the patient is still on response. As was the case for previous meetings, the debates were assigned by meeting Chairs. As such, positions taken by each of the melanoma experts during the debates may not have reflected their respective personal approach.
Keywords
Adjuvant, Anti-CTLA-4, Anti-PD-1, BRAF inhibitor, MEK inhibitor, Melanoma, Neoadjuvant, Staging immunotherapy, Targeted therapy
Pubmed
Open Access
Yes
Create date
25/04/2020 19:05
Last modification date
23/10/2020 5:26
Usage data